Clinical Trial Update: A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Lymphoseek for lymph node mapping in pediatric patients with melanoma or rhabdomyosarcoma (and other solid tumors); results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Rhabdomyosarcoma

Drugs mentioned

• Lymphoseek (tilmanocept)

Snippet

Sponsor: Cardinal Health 414, LLC | Conditions: Rhabdomyosarcoma, Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2024-06-28